Health centricity, the why behind healthcare
Dr. Colleen Strain sits down with Khosrow Shotorbani to tackle the topic of “Health centricity, the why behind healthcare” in a rapid-fire dialogue and exchange.
Speakers
Colleen Strain
Manager, Scientific Leadership and Education, Core Diagnostics
Abbott, Canada
Colleen Strain, PhD is a Scientific Manager for Global Scientific Leadership and Education at Abbott. She is also on the scientific lead for the UNIVANTS of Healthcare Excellence program and lead for the Executive Leadership Exchange program. As a champion for laboratory medicine, Colleen is passionate about driving healthcare excellence through scientific collaborations and partnerships, while maximizing value within healthcare.
Colleen’s professional and education focus on the strategic value of laboratory medicine within healthcare. Colleen is a corporate representative on the International Federations of Clinical Chemistry (IFCC)– Task Force on Outcome Studies in Laboratory Medicine and actively supports the IFCC Task Force for Corporate Members.
Colleen Strain reported the following relevant financial disclosures:
• Salary: Abbott
• Stocks/Bonds: Abbott
Khosrow Shotorbani
President, Executive Director
Project Santa Fe Foundation, USA
Founder, CEO
Lab 2.0 Strategic Services, USA
Khosrow Shotorbani is the CEO and founder of Lab 2.0 Strategic Services, LLC. He is a member of the board, and President, Executive Director of Project Santa Fe Foundation, advocating for Clinical Lab 2.0 movement.
Mr. Shotorbani was instrumental in the creation of Project Santa Fe—a initiative with like-minded executives—helping to drive new frontiers that will define future economic valuation and placement of diagnostic services and practice of laboratory medicine.
As the former President and Chief Executive Officer at TriCore Reference Laboratories, Mr. Shotorbani oversaw the corporate direction and strategy of TriCore, focusing on leadership, culture and innovation, as well as operations, growth, and the financial health of the company. He led TriCore’s initiatives based on the premise to improve health outcomes, population health and lower overall costs of delivery by predictive utilization of laboratory data.
Before joining TriCore in 2014, Mr. Shotorbani served as Senior Vice President, co-Director of Business Development and Director of Business Innovations at ARUP. He joined ARUP in 1984 as a medical technologist and while at ARUP advanced to positions with progressive responsibility over his 30-year tenure.
Khosrow Shotorbani reported no relevant financial disclosures.